Copertina

Evaluation of two clinical Centiloid analysis products for 18F‐florbetapir PET in cognitively unimpaired elders

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Frank P. DiFilippo, Stephen M. Rao
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals
di: Henry Gilreath Stephenson, et al.
Pubblicazione: (2025)

Associations of plasma p‐Tau217 with cognitive domain performance in clinically unimpaired participants: Evidence from HABS‐HD
di: Zara Najmi, et al.
Pubblicazione: (2026)

Delayed primacy recall performance predicts post mortem Alzheimer's disease pathology from unimpaired ante mortem cognitive baseline
di: Davide Bruno, et al.
Pubblicazione: (2024)

Suboptimal self‐reported sleep efficiency and duration are associated with faster accumulation of brain amyloid beta in cognitively unimpaired older adults
di: Louise N. Pivac, et al.
Pubblicazione: (2024)

Explaining variability in early stages of [18F]‐flortaucipir tau‐PET binding: Focus on sex differences
di: Dario Bachmann, et al.
Pubblicazione: (2024)

Perceptions of cognitive decline among American Indian and Alaska Native elders
di: Cole Allick
Pubblicazione: (2024)

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
di: Kay Jann, et al.
Pubblicazione: (2025)

Hallucinations and delusions are associated with elevated tau PET signal independent of age, clinical severity, and amyloid burden
di: Aubrey S Johnson, et al.
Pubblicazione: (2026)

Survey among experts on the future role of tau‐PET in clinical practice and trials
di: Marie R. Vermeiren, et al.
Pubblicazione: (2024)

Online46: Online cognitive assessments in elderly cohorts—The British 1946 birth cohort case study
di: Ziyuan Cai, et al.
Pubblicazione: (2025)

The impact of amyloid beta burden on white matter dysfunction and associated transcriptomic signatures in cognitively normal elderly individuals
di: Ziyun Li, et al.
Pubblicazione: (2025)

Cross‐cultural adaption of the computerized assessment of information processing battery (COGNITO) for an Indian longitudinal study on rural elderly
di: Ammu Lukose, et al.
Pubblicazione: (2024)

Gender differences in cognitive reserve: An impact on progression in subjective cognitive decline?
di: Giulia Giacomucci, et al.
Pubblicazione: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
di: María A. Rodríguez‐Santiago, et al.
Pubblicazione: (2024)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
di: Zheng Long Lee, et al.
Pubblicazione: (2026)

Inner and outer retinal abnormalities detected in Alzheimer's disease subjects diagnosed by amyloid PET not revealed when classified based on clinical criteria
di: Leonardo E. Ariello, et al.
Pubblicazione: (2025)

Lower odor identification in subjective cognitive decline: a meta‐analysis
di: Benoît Jobin, et al.
Pubblicazione: (2025)

The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
di: Simone Salemme, et al.
Pubblicazione: (2025)

P‐tau217 testing impact on intended management of patients presenting with cognitive impairment: A randomized clinical utility study
di: Samantha C. Burnham, et al.
Pubblicazione: (2025)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
di: Marieclaire Overton, et al.
Pubblicazione: (2025)

Correction to “The prognosis of mild cognitive impairment: A systematic review and meta‐analysis”
Pubblicazione: (2025)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
di: Andrée‐Ann Baril, et al.
Pubblicazione: (2024)

A systematic review and meta‐analysis of dual‐task outcomes in subjective cognitive decline
di: Talia Salzman, et al.
Pubblicazione: (2025)

Cognitive decline and carotid intima‐media thickness: The presumed association of two vaguely defined clinical “entities”
di: Christian Saleh
Pubblicazione: (2025)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
di: Alexandra Paget‐Blanc, et al.
Pubblicazione: (2025)

Influence of cognitive, neuropsychiatric, and diagnostic factors on financial capacity: A longitudinal analysis of the ADNI cohort
di: Milap A. Nowrangi, et al.
Pubblicazione: (2025)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
di: Samantha C. Burnham, et al.
Pubblicazione: (2026)

A virtual reality cognitive screening tool based on the six cognitive domains
di: Ngiap Chuan Tan, et al.
Pubblicazione: (2024)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
di: Sunu Mathew, et al.
Pubblicazione: (2025)

Social relationships, amyloid burden, and dementia: The ARIC‐PET study
di: Renée C. Groechel, et al.
Pubblicazione: (2024)

Factors associated with discordant visual and quantitative amyloid PET results
di: Jasmin E Guevara, et al.
Pubblicazione: (2026)

Plasma p‐tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS‐HD
di: Cellas A. Hayes, et al.
Pubblicazione: (2026)

Accuracy of clinical diagnosis of behavioral variant frontotemporal dementia: A systematic review and meta‐analysis
di: Daniele Urso, et al.
Pubblicazione: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
di: Soheil Mohammadi, et al.
Pubblicazione: (2025)

Midlife sensory and motor functions improve long‐term predictions of cognitive decline and incidence of cognitive impairment
di: Carla R. Schubert, et al.
Pubblicazione: (2024)

Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET‐MR
di: Hossein Moein Taghavi, et al.
Pubblicazione: (2024)

Plasma biomarker‐informed brain topology for cognitive resilience: applications in non‐pharmacological interventions concerning cognitive aging
di: Meishan Ai, et al.
Pubblicazione: (2026)

Inter‐scanner Aβ‐PET harmonization using barrel phantom spatial resolution matching
di: Gihan P. Ruwanpathirana, et al.
Pubblicazione: (2024)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
di: Xiang‐Sha Yin, et al.
Pubblicazione: (2025)

Accelerated biological aging is associated with cognitive performance among older adults in Mexico, India, United States, and England: A cross‐national analysis
di: Ingryd Mayara Nascimento Martins‐Pais, et al.
Pubblicazione: (2025)